← Open Payments lookup

WILLIAM DELANCEY: Open Payments

NPI 1285335760 · RACELAND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,490 in 145 payments from 14 companies in 2025. Trend: 2023 $2,167 · 2024 $2,034 · 2025 $2,490

Food & beverage: $2,379Education: $111
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)18$365
Alkermes, Inc.19$312
Otsuka America Pharmaceutical, Inc.15$301
Teva Pharmaceuticals USA, Inc.12$281
E.R. Squibb & Sons, L.L.C.14$197
Vanda Pharmaceuticals Inc.11$189
Lundbeck LLC15$179
ABBVIE INC.11$154
Neurocrine BioSciences, Inc.9$144
Janssen Pharmaceuticals, Inc6$141

Products named: CAPLYTA, REXULTI, ARISTADA, COBENFY, FANAPT, VRAYLAR, INGREZZA, Auvelity.

Industry payments across LA — which companies pay providers there.